Optimizing communication for ultrafast lung cancer biomarker testing: the UTOPIA pilot study
An ultrafast biomarker testing workflow for lung cancer, enabled by MTB-driven triage and structured team communication, can reliably generate comprehensive molecular reports within 72 h. This approach may reduce TAT-related treatment delays and support timely biomarker-guided therapy for patients with NSCLC.
Authors
- Lopez-Rios Fernando
- M. Zurera
- Torres-Jimenez Javier
- Ricardo García Luján
- Daniel Curto (ORCID: https://orcid.org/0000-0001-6133-1864)
- Marta Alonso
- Abigail Ast
- Javier De Castro
- Susana Hernandez
- Jon Zugazagoitia
- Dolores Isla
- Luis Paz-Ares
- Fatima Duran
- Helena Bote-de Cabo
- Esther Conde
- Javier Baena
Institutions
- Skidmore College (US)
- Hospital Universitario La Paz (ES)
- Research Institute Hospital 12 de Octubre (ES)
- Hospital Universitario 12 De Octubre (ES)
- Hospital La Paz Institute for Health Research (ES)
- Hospital Clínico Universitario Lozano Blesa (ES)
Publication Details
- Journal
- Lung Cancer
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1016/j.lungcan.2025.108887
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00